Targeted deletion of Traf2 allows immunosuppression-free islet allograft survival in mice.
Villanueva JE, Walters SN, Saito M, Malle EK, Zammit NW, Watson KA, Brink R, La Gruta NL, Alexander SI, Grey ST. Diabetologia. 2017 Apr; 60(4):679-689. Epub 2017 Jan 6.